thought leader relationships

By Stephanie Swanson, Strategic Marketing Manager The CEI research team is launching two new benchmarking studies that will explore the value proposition, Return-on-Investment and performance measurement of the Medical Science Liaison function. Early...

Six Tips to Help Build the Ideal Thought Leader Database As the industry awaits the release of the delayed Sunshine Act guidelines, pharmaceutical and medical device companies are benefiting from the extra time by reviewing current physician payment reporting...

By Ryan McGuire,Senior Research Analyst A study published in the British Medical Journal has received a lot of attention lately. It highlighted the prevalence of financial conflicts of interest (COI) for researchers sitting on 14 specific guideline-setting...

Under regulatory pressure for greater transparency around relationships with physicians, pharma and biotech companies have increasingly approached mid-level providers and allied health professionals as thought leaders.  There are thought leaders within every category...

Research Recommends Surveying KOLs Medical science liaison teams have an opportunity to measure and improve their performance by surveying thought leaders on their performance, according to our recent Medical Affairs study. "The New MSL Profile: Internal Thought...

Cutting Edge Information Declares Series of New Disclosure Laws Not Yet Over The wave of pharmaceutical transparency laws has not yet crested, according to research from Cutting Edge Information, and drug companies are responding with steps to reveal their compensation...

As drug companies face requirements to report all spending on physician-related activity, relationships between thought leaders and drug manufacturers are feeling the strain. Aside from individual state laws requiring companies to report payments to physicians,...

The Sunshine Act, originally drafted in 2007, has been made law as part of the Patient Protection and Affordable Care Act. What passed was really a revised version of the original, of course, but the Sunshine Act is now the law of the land, and that will impact...

New Study Provides Benchmarks and Best Practices to Build Medical Science Liaison Teams from the Ground Up The two most important factors that biopharmaceutical companies consider as they build their Medical Science Liaison (MSL) and other field-based medical...

Public scrutiny regarding relationships between thought leaders and drug makers has reached a boiling point. Changes in various policies and regulations have altered the nature of physician-industry relationships, including compensation. These changes yield a net...